Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Statins291 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26364 | 20584230 | Int J Clin Pract | Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26404 | 23148155 | Ther Adv Endocrinol Metab | Advances in the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A26478 | 20415685 | Diabetes Obes Metab | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26483 | 20388946 | J Physiol Pharmacol | Therapy of nonalcoholic fatty liver disease: current status. | 2009 | Details |
| A26701 | 19932590 | Biomed Pharmacother | Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. | 2009 | Details |
| A26862 | 19627660 | Curr Treat Options Cardiovasc Med | Use of statins in patients with liver disease. | 2009 | Details |
| A27358 | 18564173 | Diabetes Obes Metab | Current treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27369 | 18516264 | Ther Clin Risk Manag | Treatment of non-alcoholic fatty liver disease. | 2007 | Details |
| A27442 | 18376368 | Ann Hepatol | Liver biochemistry abnormalities in a quaternary care lipid clinic database. | 2008 | Details |
| A27469 | 18330098 | Acta Gastroenterol Belg | Statins in hepatobiliary diseases: effects, indications and risks. | 2008 | Details |
| A27520 | 18201181 | Int J Clin Pract | Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study. | 2008 | Details |
| A27577 | 17935056 | Diab Vasc Dis Res | The role of fenofibrate in clinical practice. | 2007 | Details |
| A27716 | 17565632 | J Gastroenterol Hepatol | How should we manage patients with non-alcoholic fatty liver disease in 2007? | 2007 | Details |
| A27800 | 17400325 | J Hepatol | Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. | 2007 | Details |
| A27961 | 16871575 | Hepatology | Statins and hepatic steatosis: perspectives from the Dallas Heart Study. | 2006 | Details |
| A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
| A28474 | 12879992 | Clin Liver Dis | Hepatotoxicity of hypolipidemic drugs. | 2003 | Details |
| A29930 | 33255794 | J Clin Med | Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. | 2020 | Details |
| A34662 | 22971151 | Hepatol Res | Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet. | 2012 | Details |
| A35259 | 21276150 | Hepatol Res | Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats. | 2011 | Details |
| A35412 | 20810317 | Curr Opin Pharmacol | Mechanisms of adiponectin regulation and use as a pharmacological target. | 2010 | Details |
| A35906 | 19448566 | J Clin Gastroenterol | A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial. | 2010 | Details |
| A36088 | 19032886 | J Coll Physicians Surg Pak | A comparison of treatments offered to patients with nonalcoholic steatohepatitis. | 2008 | Details |
| A42365 | 34757151 | Clin Res Hepatol Gastroenterol | Can statins finally provide the breakthrough in the treatment of non-alcoholic fatty liver disease? | 2021 | Details |
| A42601 | 34049381 | J Clin Gastroenterol | Statins and Cancer Mortality in NAFLD: Is it Too Early to Rejoice? | 2021 | Details |
| A42672 | 33827290 | Angiology | The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42717 | 33654016 | Curr Opin Gastroenterol | Statins for treatment of chronic liver disease. | 2021 | Details |
| A42839 | 33327917 | Curr Vasc Pharmacol | Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments. | 2021 | Details |
| A42930 | 33047634 | Expert Opin Drug Saf | Statins in liver cirrhosis in a developing country: benefits overweigh the risk? | 2020 | Details |
| A42938 | 33032512 | Curr Vasc Pharmacol | Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role? | 2021 | Details |
| A43019 | 32797344 | Dig Dis Sci | NAFLD and Statins. | 2020 | Details |
| A43208 | 32282399 | Eur J Gastroenterol Hepatol | Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort. | 2021 | Details |
| A43603 | 31310401 | Liver Int | Author response to Letter to the Editor: "Statins and non-alcoholic fatty liver disease". | 2019 | Details |
| A43693 | 31096219 | Ann Nutr Metab | Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises. | 2019 | Details |
| A43702 | 31081583 | Liver Int | Statins and non-alcoholic fatty liver disease. | 2019 | Details |
| A43913 | 30473472 | Hepatobiliary Pancreat Dis Int | Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma. | 2018 | Details |
| A44094 | 29768950 | Expert Rev Gastroenterol Hepatol | Statins in liver disease: not only prevention of cardiovascular events. | 2018 | Details |
| A44260 | 29210655 | Curr Vasc Pharmacol | Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis. | 2018 | Details |
| A44382 | 28752925 | Liver Transpl | Management of portal hypertension before and after liver transplantation. | 2018 | Details |
| A44450 | 28596414 | Am J Physiol Gastrointest Liver Physiol | Letter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal? | 2017 | Details |
| A44587 | 28089090 | J Diabetes Complications | Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs. | 2016 | Details |
| A44630 | 27865560 | Metabolism | Reply to "statins and non-alcoholic steatohepatitis". | 2016 | Details |
| A44639 | 27842716 | Metabolism | Response letter: Statins and non-alcoholic steatohepatitis. | 2016 | Details |
| A44641 | 27836113 | Metabolism | Statins and non-alcoholic steatohepatitis. | 2016 | Details |
| A44888 | 26957864 | J Pharm Bioallied Sci | Statins and its hepatic effects: Newer data, implications, and changing recommendations. | 2016 | Details |
| A44944 | 26654031 | Am J Cardiol | Statins for Improving Myocardial Perfusion in Patients With Nonalcoholic Fatty Liver Disease Undergoing Percutaneous Coronary Intervention. | 2015 | Details |
| A45002 | 26456845 | J Hepatol | Statins and non-alcoholic steatohepatitis. | 2015 | Details |
| A45045 | 26308759 | Altern Ther Health Med | Red Yeast Rice Plus Berberine: Practical Strategy for Promoting Vascular and Metabolic Health. | 2015 | Details |
| A45235 | 25565897 | HIV AIDS (Auckl) | Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. | 2014 | Details |
| A45524 | 24143116 | Diabetes Metab Syndr Obes | Hepatic function and the cardiometabolic syndrome. | 2013 | Details |
| A45773 | 22823912 | J Gastroenterol Hepatol | Enhancing organ pool by statins: is this the future? | 2012 | Details |
| A45809 | 25083232 | Ther Adv Drug Saf | Safety of statins: an update. | 2012 | Details |
| A45831 | 22487461 | Dig Liver Dis | If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? | 2012 | Details |
| A45834 | 22471112 | Rev Med Suisse | [Lipid-lowering treatment and liver dysfunction]. | 2012 | Details |
| A46043 | 21441697 | Circ J | Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-. | 2011 | Details |
| A46052 | 21404982 | Am Fam Physician | Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity. | 2011 | Details |
| A46211 | 20360293 | Mayo Clin Proc | Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. | 2010 | Details |
| A46272 | 19877024 | Liver Transpl | Obesity, hyperlipidemia, and metabolic syndrome. | 2009 | Details |
| A46320 | 19555426 | Cardiovasc Ther | Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk. | 2009 | Details |
| A46437 | 18666246 | Hepatology | Statins in liver disease: a molehill, an iceberg, or neither? | 2008 | Details |
| A46484 | 18363535 | Pharmacotherapy | Safety of statin therapy in patients with preexisting liver disease. | 2008 | Details |
| A46545 | 17723922 | Clin Liver Dis | Lipid-lowering agents that cause drug-induced hepatotoxicity. | 2007 | Details |
| A46649 | 16907904 | Aliment Pharmacol Ther | Statins for non-alcoholic fatty liver disease: a new indication? | 2006 | Details |
| A46734 | 16098839 | Am J Cardiol | Management of dyslipidemia in patients with complicated metabolic syndrome. | 2005 | Details |
| A46788 | 15547646 | Angiology | Prevention and treatment of the metabolic syndrome. | 2005 | Details |
| A46808 | 15151470 | Expert Rev Cardiovasc Ther | Treatment of metabolic syndrome. | 2004 | Details |
| A47624 | 34816633 | Hepatol Commun | Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol. | 2021 | Details |
| A47864 | 30660733 | Gastroenterology | Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis. | 2019 | Details |
| A48040 | 25904829 | Gastroenterol Hepatol (N Y) | Effects of statins on the risk of hepatocellular carcinoma. | 2014 | Details |
| A48042 | 25866507 | Gastroenterol Res Pract | Treatment of nonalcoholic steatohepatitis in adults: present and future. | 2015 | Details |
| A48620 | 32865979 | Biochemistry | Hepatocellular Carcinoma and Statins. | 2020 | Details |
| A48657 | 32139553 | Gut | Cirrhosis as new indication for statins. | 2020 | Details |
| A48814 | 27734263 | Med Oncol | Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma. | 2016 | Details |
| A48906 | 24838495 | Dig Dis Sci | Statin use in patients with cirrhosis: a retrospective cohort study. | 2014 | Details |
| A49036 | 20570793 | Orv Hetil | [Role of environmental factors in the etiology of hepatocellular carcinoma]. | 2010 | Details |
| A49193 | 14520852 | Ter Arkh | [Clinicomorphological changes of liver in atherogenic dyslipidemia and after treatment with statins]. | 2003 | Details |
| A49340 | 35783879 | Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. | 2022 | Details |
| A49350 | 35781090 | Ann Hepatol | Safety and efficacy of dyslipidemia treatment in NAFLD Patients: a Meta-analysis of randomized controlled trials. | 2022 | Details |
| A49514 | 35728963 | Cas Lek Cesk | Statins and liver. | 2022 | Details |
| A49563 | 35712812 | Hepatol Commun | Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. | 2022 | Details |
| A50561 | 35339670 | Clin Gastroenterol Hepatol | Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects. | 2022 | Details |
| A50672 | 35307033 | BMC Med | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study). | 2022 | Details |
| A50797 | 35262903 | Dig Dis Sci | Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans. | 2022 | Details |
| A51047 | 21348145 | Nat Rev Cardiol | Pharmacotherapy: Statins are safe in NAFLD. | 2011 | Details |
| A51128 | 35607596 | Drug Des Devel Ther | Effects of Ethanolic Extract of Schisandra sphenanthera on the Pharmacokinetics of Rosuvastatin in Rats. | 2022 | Details |
| A51539 | 35464261 | Diabetes Metab Syndr Obes | Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study. | 2022 | Details |
| A51884 | 33470195 | Am Heart J | Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance. | 2020 | Details |
| A52228 | 29908359 | Clin Gastroenterol Hepatol | Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection. | 2018 | Details |
| A52262 | 29524177 | J Endocrinol Invest | Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older. | 2018 | Details |
| A52510 | 26209814 | Atherosclerosis | Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis. | 2015 | Details |
| A52783 | 22005032 | Biochim Biophys Acta | Hypertriglyceridemia secondary to obesity and diabetes. | 2011 | Details |